Life Science Nation (LSN) runs the Redefining Early Stage Investments (RESI) Conference series to accelerate opportunities for you. RESI is an established and ongoing conference series that provides an international venue for early-stage life science companies across Biotech, Medtech, Diagnostics and Digital Health, to source investors from around the globe, create relationships, and potentially, secure funding. RESI NYC will expand to include the earliest stage companies from the discovery stage through the venture stage: companies seeking grants, seed, angel, series A, and series B funding.